Abstract:The current results show that ischemic preconditioning protects the liver graft from subsequent long-term cold preservation-reperfusion injury in a rat liver transplantation model. The protective role of ischemic preconditioning may be mediated by the endogenous production of NO.
“…2,[30][31][32][33] We examine the available evidence and attempt to provide some potential reasons for this disparity.…”
Section: Disparity Between the Bench And Bedsidementioning
confidence: 99%
“…The merits of this composite endpoint were discussed in the Severity of Ischemia and RP Injury section, subsection Liver Transplantation. Remote preconditioning via limb ischemia 81,82 (1) Applicable to DCD donors; (2) Inexpensive Hypertonic saline dextran 83,84 (1) Volume enhancement, especially in donors and applicable to DCD donors; (2) Inexpensive Anesthetic preconditioning (volatile anesthetics, nitric oxide) 3,4,85 (1) May not be feasible in all donor hospitals; (2) Nitric oxide is expensive Pharmacologic preconditioning (nitrites, adenosine, interleukin-10) 2,6,7 (1) More expensive; (2) Potential side effects of agents NOTE: In contradistinction to ischemic preconditioning, all listed modalities are applicable in both liver donors and recipients. They share avoidance of direct organ ischemia and, when used in deceased donors, have the potential to benefit recipients of many organs.…”
Section: Criteria and Reporting Of Rp Injurymentioning
confidence: 99%
“…Preconditioning strategies effective in the laboratory include ischemic preconditioning (IPC), anesthetic preconditioning, hyperthermic or heat-shock preconditioning, and pharmacological preconditioning. [1][2][3][4][5][6][7] In the past decade, serious efforts have commenced to translate some of the robust benefits of preconditioning against ischemia reperfusion (RP) to the clinical arena. Although all of the preconditioning methods offer potential clinical benefits, much of the initial translational effort has focused on IPC, probably due to its extensive and consistently beneficial laboratory experience.…”
mentioning
confidence: 99%
“…[10][11][12][13][14][15] In laboratory animals and humans, IPC of the liver may be induced either by a single short period of ischemia or multiple short cycles of ischemia (or intermittent hilar clamping). 16 In a rat liver transplant model, Yin et al 2 investigated single IPC periods ranging between 5 and 20 minutes and showed that 10 minutes induced the best protection. Although 10 to 15 minutes of RP after the preconditioning ischemia has become a methodological tradition following the initial laboratory work, more recent work by Glanemann et al, 17 in rat liver warm ischemia, showed that 30 to 45 minutes of RP were more effective than 5 to 15 minutes.…”
Utilization of ischemic preconditioning to ameliorate ischemia/reperfusion injury has been extensively studied in various organs and species for the past two decades. While hepatic ischemic preconditioning in animals has been largely beneficial, translational efforts in the two clinical contexts-liver resection and decreased donor liver transplantation-have yielded mixed results. This review is intended to critically examine the translational data and identify some potential reasons for the disparate clinical results, and highlight some issues for further studies.
“…2,[30][31][32][33] We examine the available evidence and attempt to provide some potential reasons for this disparity.…”
Section: Disparity Between the Bench And Bedsidementioning
confidence: 99%
“…The merits of this composite endpoint were discussed in the Severity of Ischemia and RP Injury section, subsection Liver Transplantation. Remote preconditioning via limb ischemia 81,82 (1) Applicable to DCD donors; (2) Inexpensive Hypertonic saline dextran 83,84 (1) Volume enhancement, especially in donors and applicable to DCD donors; (2) Inexpensive Anesthetic preconditioning (volatile anesthetics, nitric oxide) 3,4,85 (1) May not be feasible in all donor hospitals; (2) Nitric oxide is expensive Pharmacologic preconditioning (nitrites, adenosine, interleukin-10) 2,6,7 (1) More expensive; (2) Potential side effects of agents NOTE: In contradistinction to ischemic preconditioning, all listed modalities are applicable in both liver donors and recipients. They share avoidance of direct organ ischemia and, when used in deceased donors, have the potential to benefit recipients of many organs.…”
Section: Criteria and Reporting Of Rp Injurymentioning
confidence: 99%
“…Preconditioning strategies effective in the laboratory include ischemic preconditioning (IPC), anesthetic preconditioning, hyperthermic or heat-shock preconditioning, and pharmacological preconditioning. [1][2][3][4][5][6][7] In the past decade, serious efforts have commenced to translate some of the robust benefits of preconditioning against ischemia reperfusion (RP) to the clinical arena. Although all of the preconditioning methods offer potential clinical benefits, much of the initial translational effort has focused on IPC, probably due to its extensive and consistently beneficial laboratory experience.…”
mentioning
confidence: 99%
“…[10][11][12][13][14][15] In laboratory animals and humans, IPC of the liver may be induced either by a single short period of ischemia or multiple short cycles of ischemia (or intermittent hilar clamping). 16 In a rat liver transplant model, Yin et al 2 investigated single IPC periods ranging between 5 and 20 minutes and showed that 10 minutes induced the best protection. Although 10 to 15 minutes of RP after the preconditioning ischemia has become a methodological tradition following the initial laboratory work, more recent work by Glanemann et al, 17 in rat liver warm ischemia, showed that 30 to 45 minutes of RP were more effective than 5 to 15 minutes.…”
Utilization of ischemic preconditioning to ameliorate ischemia/reperfusion injury has been extensively studied in various organs and species for the past two decades. While hepatic ischemic preconditioning in animals has been largely beneficial, translational efforts in the two clinical contexts-liver resection and decreased donor liver transplantation-have yielded mixed results. This review is intended to critically examine the translational data and identify some potential reasons for the disparate clinical results, and highlight some issues for further studies.
“…Preconditioning also appears to be a useful strategy against the deleterious effects of cold storage-reperfusion injury, since it was observed that ischemic-preconditioned grafts had reduced levels of transaminases and TNF-␣, as well as augmented bile flow and improved tissue blood flow [92][93][94]. Accordingly, in a recent publication it was observed that preconditioned rat livers were more tolerant against cold-storage-reperfusion injury, most probably due to a decreased production of O 2 Ϫ• by Kupffer cells.…”
Section: Protective Mechanisms Of Delayed Ischemic Preconditioningmentioning
Abstract-Hepatic ischemia/reperfusion injury has immediate and deleterious effects on the outcome of patients after liver surgery. The precise mechanisms leading to the damage have not been completely elucidated. However, there is substantial evidence that the generation of oxygen free radicals and disturbances of the hepatic microcirculation are involved in this clinical syndrome. Microcirculatory dysfunction of the liver seems to be mediated by sinusoidal endothelial cell damage and by the imbalance of vasoconstrictor and vasodilator molecules, such as endothelin (ET), reactive oxygen species (ROS), and nitric oxide (NO). This may lead to no-reflow phenomenon with release of proinflammatory cytokines, sinusoidal plugging of neutrophils, oxidative stress, and as an ultimate consequence, hypoxic cell injury and parenchymal failure. An inducible potent endogenous mechanism against ischemia/reperfusion injury has been termed ischemic preconditioning. It has been suggested that preconditioning could inhibit the effects of different mediators involved in the microcirculatory dysfunction, including endothelin, tumor necrosis factor-␣, and oxygen free radicals. In this review, we address the mechanisms of liver microcirculatory dysfunction and how ischemic preconditioning could help to provide new surgical and/or pharmacological strategies to protect the liver against reperfusion damage.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.